Financial Analysis: Caribou Biosciences Inc (CRBU)’s Ratios Unveil Key Insights

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Caribou Biosciences Inc’s stock clocked out at $1.91, down -1.55% from its previous closing price of $1.94. In other words, the price has decreased by -$1.55 from its previous closing price. On the day, 1.28 million shares were traded. CRBU stock price reached its highest trading level at $1.95 during the session, while it also had its lowest trading level at $1.82.

Ratios:

To gain a deeper understanding of CRBU’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.38 and its Current Ratio is at 7.38. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Evercore ISI on June 03, 2024, Downgraded its rating to In-line and sets its target price to $3 from $13 previously.

On October 31, 2023, Evercore ISI started tracking the stock assigning a Outperform rating and target price of $13.Evercore ISI initiated its Outperform rating on October 31, 2023, with a $13 target price.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBU now has a Market Capitalization of 172955664 and an Enterprise Value of -28581368. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.85 while its Price-to-Book (P/B) ratio in mrq is 0.62. Its current Enterprise Value per Revenue stands at -2.491 whereas that against EBITDA is 0.181.

Stock Price History:

Over the past 52 weeks, CRBU has reached a high of $8.33, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -8.16%, while the 200-Day Moving Average is calculated to be -32.07%.

Shares Statistics:

It appears that CRBU traded 1.29M shares on average per day over the past three months and 1450980 shares per day over the past ten days. A total of 90.55M shares are outstanding, with a floating share count of 79.18M. Insiders hold about 12.56% of the company’s shares, while institutions hold 58.66% stake in the company. Shares short for CRBU as of 1732838400 were 8616165 with a Short Ratio of 6.68, compared to 1730332800 on 9940336. Therefore, it implies a Short% of Shares Outstanding of 8616165 and a Short% of Float of 9.9700004.

Most Popular